Keyphrases
Adalimumab
25%
Anti-adalimumab Antibodies
25%
Circulating Cytokines
25%
Crohn's Disease
56%
Cytokine Receptor
25%
Disease Monitoring
25%
Enzyme-linked Immunosorbent Assay (ELISA)
23%
Immunogenicity
25%
Immunomodulator
18%
Immunomodulatory Therapy
25%
Inflammatory Bowel Disease
100%
Infliximab
50%
Methotrexate
31%
Pharmacokinetics
38%
Pharmacology
25%
Radioimmunoassay
17%
Reporter Gene Assay
23%
Thiopurines
37%
Tollip
25%
Treatment Failure
36%
Tumor Necrosis Factor-α
50%
Pharmacology, Toxicology and Pharmaceutical Science
Adalimumab
25%
Crohn's Disease
25%
Immunomodulating Agent
37%
Inflammatory Bowel Disease
75%
Infliximab
25%
Mercaptopurine
43%
Methotrexate
37%
Tumor Necrosis Factor Antibody
25%
Immunology and Microbiology
Crohn's Disease
51%
Cytokine
25%
Cytokine Receptor
25%
Inflammatory Bowel Disease
25%
Infliximab
50%
TLR8
25%
Tumor Necrosis Factor
25%
